SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI) -- Ignore unavailable to you. Want to Upgrade?

To: Thomas M. who wrote (556)1/19/2000 6:29:00 PM
From: OldAIMGuy  Respond to of 1154
 
Hi Tom, With the selling I've been doing (sold 11% of my remaining GENE position at $25-1/4 today) I now have more Cash Reserve for GENE than I had total value of the stock last year. It's a nice feeling.

Best regards, Tom



To: Thomas M. who wrote (556)1/19/2000 7:06:00 PM
From: Starlight  Read Replies (2) | Respond to of 1154
 
I feel fortunate to have gotten in at an average of about $13 -- just about 3 weeks ago! That's almost a double already!



To: Thomas M. who wrote (556)1/20/2000 7:47:00 PM
From: Richaaard  Read Replies (1) | Respond to of 1154
 
GENE is nowhere near the bargain it was last summer.

I wouldn't assume that. Many people thought the same thing about YHOO 1 1/2 years ago when it ran from the $20 to $50 range in the span of a couple weeks. If you sold at $50........YOU LOSE!

Seriously, we could look back on this $22 price in a year or two and chuckle the same way.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News